Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Yury Malyshev Added: 1 year ago
AF Symposium 24 — Dr Yury Malyshev (Mount Sinai Hospital, US) joins us to discuss the findings from three studies focusing on the long-term effects of pulsed-field ablation (PFA) on coronary arteries.QuestionsWhat is known currently about the effect of PFA in Coronary Arteries? What is the importance of this topic?What was the study design and cohort?What are the key findings?Who are the take… View more
Author(s): Vivek Reddy , Boris Schmidt , Josef Kautzner , et al Added: 2 years ago
In this engaging video series, we are joined by an esteemed faculty, co-chaired byDr Claire Martin(Royal Papworth Hospital, UK) andProf Josef Kautzner(Charles University Medical School, Czech Republic) who will present and discuss a series of topics surrounding the clinical evidence behind pulsed field ablation (PFA). Dr Vivek Reddy(The Mount Sinai Hospital, US) andDr Boris Schmidt(Centrum… View more
Author(s): Lucas Boersma Added: 4 months ago
ESC Congress 2025 - FARADISE Registry finds FARAPULSE™ pulsed field ablation (PFA) system safe and easy to use, with an 80% clinical effectiveness at one year in paroxysmal AF.Prof Lucas Boersma (St Antonius Hospital, Nieuwegein, NL) joins us to discuss one-year findings from the observational, prospective, single-arm FARADISE global registry (NCT05501873) which collected real-world data from up… View more
Added: 5 months ago Source:  Radcliffe CVRM
A prespecified secondary analysis of the EAST-AFNET 4 trial has found that the benefits of an early rhythm control strategy for patients with recently diagnosed atrial fibrillation (AF) are maintained regardless of whether patients have obesity or diabetes.¹ These findings suggest that clinicians should not withhold this therapeutic approach based on these common metabolic comorbidities.The… View more
Dr Emily Tomasulo is a Hematologist/Oncologist who specializes in B-cell lymphoma and cellular therapy at Pennsylvania Hospital and the Hospital of the University of Pennsylvania. She sits on ECOG-ACRIN Leukemia Committee and her research and clinical interests focus on the use of targeted and cellular therapies in B-cell malignancies with particular attention to cardiovascular adverse effects… View more